Literature DB >> 11331872

ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1.

T Harada1, T Morooka, S Ogawa, E Nishida.   

Abstract

The classical mitogen-activated protein kinase (MAPK; also known as extracellular-signal-regulated kinase), ERK cascade has been shown to have a crucial role in cell proliferation and differentiation. In PC12 cells, sustained activation of ERK induced by nerve-growth factor (NGF) is essential for neuronal differentiation. However, downstream targets of ERK that are essential for neuronal differentiation have not been defined. Here we show that NGF induces strong, sustained expression of p35, the neuron-specific activator of cyclin-dependent kinase 5 (Cdk5), through activation of the ERK pathway. The induced kinase activity of Cdk5 is required for NGF-induced neurite outgrowth. Our results indicate that sustained activation of ERK is necessary and sufficient for strong induction of p35. Furthermore, the transcription factor Egr1, is induced by NGF through the ERK pathway and mediates induction of p35 by ERK. Our results thus define an essential signalling pathway, downstream of ERK/MAPK, that leads to neuronal differentiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331872     DOI: 10.1038/35074516

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  103 in total

1.  A dominant negative Egr inhibitor blocks nerve growth factor-induced neurite outgrowth by suppressing c-Jun activation: role of an Egr/c-Jun complex.

Authors:  Yechiel Levkovitz; Jay M Baraban
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

2.  Nerve growth factor controls GAP-43 mRNA stability via the phosphoprotein ARPP-19.

Authors:  Nina Irwin; Steven Chao; Luda Goritchenko; Atsuko Horiuchi; Paul Greengard; Angus C Nairn; Larry I Benowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

3.  Sputa nerve growth factor forms a preferable substitute to mouse 7S-beta nerve growth factor.

Authors:  Dawn C-I Koh; A Armugam; K Jeyaseelan
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

4.  Global expression analysis identified a preferentially nerve growth factor-induced transcriptional program regulated by sustained mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) and AP-1 protein activation during PC12 cell differentiation.

Authors:  Steven Mullenbrock; Janki Shah; Geoffrey M Cooper
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

5.  Local phosphatidylinositol 3,4,5-trisphosphate accumulation recruits Vav2 and Vav3 to activate Rac1/Cdc42 and initiate neurite outgrowth in nerve growth factor-stimulated PC12 cells.

Authors:  Kazuhiro Aoki; Takeshi Nakamura; Keiko Fujikawa; Michiyuki Matsuda
Journal:  Mol Biol Cell       Date:  2005-02-23       Impact factor: 4.138

6.  NF-kappaB/Egr-1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell death.

Authors:  Raphaël Thyss; Virginie Virolle; Véronique Imbert; Jean-François Peyron; Daniel Aberdam; Thierry Virolle
Journal:  EMBO J       Date:  2004-12-16       Impact factor: 11.598

7.  Role of the JAKs/STATs pathway in the intracellular calcium changes induced by interleukin-6 in hippocampal neurons.

Authors:  D I Orellana; R A Quintanilla; C Gonzalez-Billault; R B Maccioni
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

Review 8.  Protein kinases and addiction.

Authors:  Anna M Lee; Robert O Messing
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

9.  Tissue-type plasminogen activator regulates p35-mediated Cdk5 activation in the postsynaptic terminal.

Authors:  Ariel Diaz; Valerie Jeanneret; Paola Merino; Patrick McCann; Manuel Yepes
Journal:  J Cell Sci       Date:  2019-02-28       Impact factor: 5.285

10.  Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma.

Authors:  Lijuan Chen; Siqing Wang; Yiming Zhou; Xiaosong Wu; Igor Entin; Joshua Epstein; Shmuel Yaccoby; Wei Xiong; Bart Barlogie; John D Shaughnessy; Fenghuang Zhan
Journal:  Blood       Date:  2009-10-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.